indomethacin has been researched along with Cardiac Remodeling, Ventricular in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, J | 1 |
Tang, X | 1 |
Liang, X | 1 |
Wen, Q | 1 |
Zhang, S | 1 |
Xuan, F | 1 |
Jian, J | 1 |
Lin, X | 1 |
Huang, R | 1 |
1 other study available for indomethacin and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on Pressure Overload-Induced Cardiac Remodeling in Rats and the Endothelial Mechanisms Based on PGI2.
Topics: Animals; Aorta, Abdominal; Cardiovascular Agents; Chalcones; Constriction, Pathologic; Endothelium, | 2015 |